Thermo Fisher Scientific to Acquire Patheon, a Leading Contract Development and Manufacturing Organization (CDMO)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Turkish Stocks Fall 6%, Triggering Market-wide Circuit Breaker - Bloomberg
Jefferies Remains Sidelined on Thermo Fisher Scientific (TMO) Following Announced Acquisition of PTHN
May 16, 2017 7:25 AM EDTJefferies reiterated a Hold rating and $175.00 price target on Thermo Fisher Scientific (NYSE: TMO) following the company's announced move to acquire PTHN. TMO is paying $35/sh in cash and assuming ~$2B of net debt, implying an EV of $7.2B.
The deal marks... More
Evercore ISI Downgrades Patheon Holdings (PTHN) to In Line Amid Takeoer
May 15, 2017 2:57 PM EDTEvercore ISI downgraded Patheon Holdings (NYSE: PTHN) from Outperform to In Line with a price target of $35.00 (from $30.50) after the company agreed to be acquired by TMO.
For an analyst ratings summary and ratings history on Patheon Holdings... More
